NGM·Healthcare·$316M·#318 / 520 in Healthcare

TKNO Alpha Teknova, Inc.

36HIGH RISK

CATEGORY BREAKDOWN

GROWTH12
QUALITY27
STABILITY35
VALUATION57
GOVERNANCE74

METRIC BREAKDOWN

Revenue Growth (YoY)

Year-over-year revenue growth rate

+7.4%
12

> 50% strong

Gross Margin

Revenue retained after direct costs

33.2%
45

> 50% strong

Cash Runway

Months of cash at current burn rate

8 months
21

> 24 months ideal

Debt / Equity

Total debt relative to shareholder equity

41.1%
64

< 25% strong

Price / Sales

Market cap relative to trailing revenue

7.6x
57

< 3x strong

Rule of 40

Growth rate plus operating margin

-35
0

> 40 excellent

Insider Ownership

Percentage of shares held by insiders

9.3%
62

> 20% strong

Share Dilution (12M)

Share count increase over last 12 months

+0.2%
99

< 5% ideal

SCORE HISTORY

COMPARE TKNO WITH…

TKNOvs

OR QUICK-COMPARE SECTOR PEERS

SCORE ALERT

Get notified when TKNO's score changes by 5+ points.

DATA INFO

Last updated: Jul 1, 2026

Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.